Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CXCR4 | 6 | 2018 | 74 | 1.900 |
Why?
|
| Prostatic Neoplasms | 9 | 2020 | 1092 | 1.370 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2013 | 59 | 1.120 |
Why?
|
| Cannabinoids | 3 | 2023 | 73 | 0.960 |
Why?
|
| Chemokine CXCL12 | 2 | 2018 | 32 | 0.830 |
Why?
|
| Neoplasms | 3 | 2023 | 1377 | 0.780 |
Why?
|
| Hallucinogens | 1 | 2023 | 29 | 0.750 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2012 | 108 | 0.680 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.680 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 532 | 0.670 |
Why?
|
| Oxidative Stress | 5 | 2020 | 1003 | 0.620 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2018 | 38 | 0.600 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 143 | 0.600 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 2 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 299 | 0.550 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 23 | 0.550 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 34 | 0.540 |
Why?
|
| Cell Nucleus | 3 | 2020 | 383 | 0.540 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 1723 | 0.500 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 2676 | 0.470 |
Why?
|
| Protein Multimerization | 1 | 2016 | 115 | 0.440 |
Why?
|
| Karyopherins | 1 | 2013 | 7 | 0.400 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 20 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 1 | 0.380 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 196 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 105 | 0.320 |
Why?
|
| Apoptosis | 7 | 2020 | 1568 | 0.300 |
Why?
|
| Signal Transduction | 3 | 2014 | 2157 | 0.300 |
Why?
|
| Cell Movement | 4 | 2018 | 655 | 0.270 |
Why?
|
| Humans | 19 | 2023 | 43102 | 0.270 |
Why?
|
| Down-Regulation | 3 | 2018 | 456 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 165 | 0.260 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 58 | 0.250 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 140 | 0.250 |
Why?
|
| Male | 11 | 2020 | 23409 | 0.220 |
Why?
|
| Phosphorylation | 4 | 2013 | 986 | 0.210 |
Why?
|
| Cell Survival | 5 | 2020 | 945 | 0.200 |
Why?
|
| Receptors, Cannabinoid | 1 | 2023 | 31 | 0.200 |
Why?
|
| Thiazoles | 2 | 2014 | 76 | 0.190 |
Why?
|
| Endocannabinoids | 1 | 2023 | 41 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2016 | 883 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 968 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1455 | 0.180 |
Why?
|
| Indoles | 2 | 2014 | 187 | 0.180 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 134 | 0.180 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 190 | 0.170 |
Why?
|
| Culture Media, Serum-Free | 1 | 2020 | 44 | 0.160 |
Why?
|
| Protein Transport | 1 | 2020 | 296 | 0.150 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 436 | 0.150 |
Why?
|
| Minority Groups | 2 | 2022 | 690 | 0.150 |
Why?
|
| Peroxidase | 1 | 2019 | 57 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 78 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2020 | 346 | 0.140 |
Why?
|
| Benzylamines | 1 | 2018 | 7 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 127 | 0.130 |
Why?
|
| Phenotype | 1 | 2020 | 780 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2020 | 358 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2022 | 502 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2018 | 238 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2008 | 183 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 508 | 0.110 |
Why?
|
| Cathepsin D | 1 | 2014 | 16 | 0.110 |
Why?
|
| RNA Interference | 2 | 2012 | 247 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 49 | 0.100 |
Why?
|
| Arabidopsis | 1 | 2014 | 103 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 934 | 0.100 |
Why?
|
| Sesquiterpenes | 1 | 2012 | 38 | 0.090 |
Why?
|
| DNA Primers | 1 | 2013 | 294 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 100 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 88 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 213 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1019 | 0.090 |
Why?
|
| Animals | 4 | 2016 | 16992 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 652 | 0.090 |
Why?
|
| Base Sequence | 1 | 2013 | 983 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1180 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1542 | 0.080 |
Why?
|
| Female | 3 | 2018 | 24698 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 209 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 256 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 712 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2007 | 21 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 60 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2007 | 26 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 237 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 173 | 0.060 |
Why?
|
| Hela Cells | 1 | 2007 | 376 | 0.060 |
Why?
|
| Mutation | 2 | 2007 | 1177 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 241 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 333 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2007 | 536 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 1410 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 79 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 120 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 95 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 290 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 206 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 167 | 0.040 |
Why?
|
| Transfection | 2 | 2012 | 532 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 385 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 95 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 378 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 76 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 141 | 0.030 |
Why?
|
| Lysosomes | 1 | 2014 | 86 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 72 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2012 | 18 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 462 | 0.020 |
Why?
|
| Prostate | 1 | 2014 | 155 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.020 |
Why?
|
| Autophagy | 1 | 2013 | 140 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 227 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 220 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5205 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2014 | 302 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1124 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 443 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 1857 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 735 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2007 | 10 | 0.020 |
Why?
|
| Lamin Type A | 1 | 2007 | 14 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 98 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 69 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2007 | 408 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 411 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 6644 | 0.010 |
Why?
|